APPL1 endocytic adaptor as a fine tuner of Dvl2-induced transcription  by Banach-Orlowska, Magdalena et al.
FEBS Letters 589 (2015) 532–539journal homepage: www.FEBSLetters .orgAPPL1 endocytic adaptor as a ﬁne tuner of Dvl2-induced transcriptionhttp://dx.doi.org/10.1016/j.febslet.2015.01.022
0014-5793/ 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Abbreviations: AP-1, activating protein 1; APPL, adaptor protein containing
pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper
motif; CKI, casein kinase I; Dvl, Dishevelled; GST, glutathione S-transferase; JNK, c-
Jun N-terminal kinase; LRP, low-density lipoprotein receptor-related protein; MMP,
matrix metalloproteinase; NF-jB, nuclear factor jB; NuRD, nucleosome remodeling
deacetylase; PCP, planar cell polarity; PDZ, post synaptic density protein (PSD95),
Drosophila disc large tumor suppressor (Dlg1), and zonula occludens-1 protein (zo-
1); PH, pleckstrin homology; PTB, phosphotyrosine binding; TCF, T-cell factor
⇑ Corresponding author at: International Institute of Molecular and Cell Biology,
Ks. Trojdena 4, 02-109 Warsaw, Poland. Fax: +48 22 597 07 26.
E-mail address: magre@iimcb.gov.pl (M. Banach-Orlowska).
1 Present address: Department of Histology and Embryology, Center of Biostructure
Research, Medical University of Warsaw, Banacha 1b, 02-097 Warsaw, Poland.Magdalena Banach-Orlowska ⇑,1, Ewelina Szymanska, Marta Miaczynska
Laboratory of Cell Biology, International Institute of Molecular and Cell Biology, Warsaw, Poland
a r t i c l e i n f o a b s t r a c tArticle history:
Received 26 October 2014
Revised 15 January 2015
Accepted 15 January 2015
Available online 23 January 2015
Edited by Lukas Huber
Keywords:
APPL endocytic proteins
Dishevelled
Activating protein 1
Wnt signalingAPPL1 is a multifunctional endocytic adaptor which acts at different steps of various signaling path-
ways. Here we report that APPL1 interacts with Dvl2, a protein known to activate the canonical and
non-canonical Wnt pathways. APPL1 synergizes with Dvl2 and potentiates transcription driven by
AP-1 transcription factors, speciﬁcally by c-Jun, in non-canonical Wnt signaling. This function of
APPL1 requires its endosomal recruitment. Overproduction of APPL1 increases Dvl2-mediated
expression of AP-1 target gene encoding metalloproteinase 1 (MMP1) in a JNK-dependent manner.
Collectively, we propose a novel role of APPL1 as a positive regulator of Dvl2-dependent transcrip-
tional activity of AP-1.
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It is commonly accepted that endocytic proteins can regulate
cellular signaling at different levels, including transcription by
modulating the activity of nuclear factors [1,2]. APPL1 (adaptor
protein containing pleckstrin homology domain, phosphotyrosine
binding domain, and leucine zipper motif 1) and its less studied
homolog APPL2 are examples of endocytic proteins able to regulate
intracellular signaling. APPL1 localizes to a subpopulation of early
endosomes (termed APPL endosomes) due to interactions with
Rab5 and Rab21 GTPases [3,4]. However, this protein resides also
in the cytoplasm and shuttles to the nucleus partially due to inter-
actions with the NuRD complex [3,5]. APPL1 binds several trans-
membrane receptors and kinases involved in signal transduction
[6–9]. Recently, we discovered that APPL1 can induce nuclearaccumulation of RelA leading to expression of NF-jB target genes
[10]. We also showed that APPL1 and APPL2 modulate transcrip-
tion of b-catenin/TCF target genes in canonical Wnt signaling via
interactions with histone deacetylases and reptin [11].
Dishevelled (Dvl) adaptor proteins act at early stages of Wnt
signaling thanks to interactions with multiple partners [12]. Both
the canonical (b-catenin-dependent) and non-canonical Wnt path-
ways are activated by overexpression of Dvl. These primarily cyto-
plasmic proteins can also translocate to the nucleus [13,14]. Upon
overexpression they form cytosolic puncta of unclear nature, pos-
tulated to represent either protein assemblies [15] or endocytic
structures in agreement with the proposed crucial role of Dvl in
Frizzled receptor internalization [16,17].
Dvl proteins regulate the canonical Wnt pathway at, at least,
two steps: (i) ligand-induced phosphorylation of LRP5/6 receptors
and (ii) phosphorylation-dependent degradation of b-catenin. Ini-
tially, Dvl-mediated recruitment of Axin-bound GSK3b and/or CKI
kinases stimulates phosphorylation of LRP by these kinases at the
plasma membrane [18,19]. Consequentially, Dvl-mediated titra-
tion of Axin away from the b-catenin destruction complex compro-
mises phosphorylation of b-catenin, thus preventing its
subsequent degradation [20].
Planar cell polarity (PCP) signaling, one of the non-canonical
Wnt pathways, is also regulated by Dvl proteins. Dvl2 activates a
small GTPase Rac which in turn stimulates the c-Jun N-terminal
kinase (JNK), a potent regulator of the PCP pathway [21,22].
This mechanism operates during dendrite growth [13] and cell
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and activate Daam1 [24] which induces ROCK kinase responsible
for cytoskeleton remodeling [25].
The JNK substrate c-Jun belongs to the family of activating pro-
tein 1 (AP-1) transcription factors. They act as dimers of basic leu-
cine zipper (bZIP) domain containing mainly proteins which
belong to the subfamilies of Jun (c-Jun, JunB, JunD) and Fos (c-
Fos, FosB, Fra1 and Fra2) (reviewed by [26]). AP-1 homo- and het-
erodimers bind DNA at the heptamer consensus sequence known
as the TPA-responsive element (TRE) [27]. A large number of AP-
1 proteins provide broad combinatorial possibilities of dimers with
different binding speciﬁcities to tightly regulate expression of
numerous genes [28]. It was demonstrated that c-Jun exhibits tran-
scriptional activity when phosphorylated at Ser63 and Ser73 by the
JNK kinase [29]. Moreover, one of the c-Jun transcriptional targets
is c-Jun itself since its promoter region contains a consensus
sequence for AP-1 binding [30]. Probably, this positive autoregula-
tion loop constitutes a mechanism for prolonging the signals from
extracellular stimuli.
Here, we report that APPL1 interacts and synergizes with Dvl2
to regulate AP-1-dependent transcription in non-canonical Wnt
signaling.2. Materials and methods
2.1. Cell lines and transfections
HEK293T, Hela, Wnt3a-expressing mouse L cells (ATCC; CRL-
2647) and parental L cells (CRL-2648) were maintained in DMEM
with 10% fetal bovine serum, 2 mM L-glutamine. The conditioned
media from L cells were obtained as recommended by the supplier.
siRNA (30 nM) was delivered to HEK293T cells using HiPerFect
reagent (Qiagen), plasmids were delivered with Lipofectamine
2000 (Invitrogen) according to manufacturers’ instructions. For
immunoprecipitation assay HEK293T cells were transfected in 6-
well plate with 2 lg of each plasmid and harvested 24 or 48 h after
transfection. For RT-PCR experiments HEK293T cells were transfec-
ted in 12-well plate with 1.5 lg of each plasmid and harvested 24 h
after transfection. For luciferase assay HEK293T cells were trans-
fected for 24 h in 96-well plate with 50 ng of reporter (pAP-1-
luc) plus 25 ng of normalization construct (pRL-TK) along with dif-
ferent amounts of APPL1- or Dvl2-encoding plasmids, or with siR-
NA for 48 h and then with plasmid DNA for the next 24 h. For
microscopic analysis Hela cells were transfected in 24-well plates
with 0.5 lg of Dvl2-encoding plasmid using FuGene (Roche)
reagent and ﬁxed 24 h after transfection.
2.2. siRNA, plasmids
ON-TARGETplus SMARTpool siRNA targeting human APPL1
(Dharmacon, cat # L-005138-00-0005) and non-targeting control
SMARTpool (cat# D-001810-10-20) were employed at 30 nM
concentration.
The following plasmids were used: pCMV-Dvl2 (kind gift from
Prof. Jacek Otlewski, University of Wroclaw); pcDNA3-based con-
structs of untagged andN-terminallymyc-tagged APPL1 and APPL2,
pEYFP-C3-APPL1DC4, pcDNA3-MycHisB-APPL1DC4, pcDNA3-
MycHisB-APPL1 K280E/Y283C/G319R, pcDNA3-MycHisB-APPL1-
A318D, pcDNA3-MycHisB-APPL1-G320A [3,4]; pRL-TK (kind gift
from Dr. Vladimir Korinek, Institute of Molecular Genetics, Prague),
pAP-1-luc (Stratagene), A-Fos constructwas provided byDr. Charles
Vinson (Addgene plasmid #33353) [31]. pGEX-6P-3/APPL1-N
(amino acids 1–428), pGEX-6P-3/APPL1-C (amino acids 429–709),
pGEX-6P-3/APPL2-N (amino acids 1–377), pGEX-6P-3/APPL2-C
(amino acids 378–664) were previously described [3,11].2.3. Antibodies
Rabbit polyclonal anti-APPL2 (Ab5002) and anti-APPL2
(Ab4567) antibodies were previously described [11]. Anti-Dvl2
(sc-8026), anti-phospho-c-Jun Ser63/73 (sc-16312), anti-c-Jun
(sc-45), anti-GAPDH (sc-25778), anti-lamin A/C (sc-7292) and
anti-b-catenin (sc7199) were from Santa Cruz Biotechnology;
anti-Myc tag (05-419) and anti-Axin1 (2087) from Cell Signaling;
anti-b-catenin (610154) from BD Transduction Laboratories and
anti-GSK3b (44-610) from Invitrogen.
The following secondary antibodies were used: horseradish
peroxidase-conjugated (Jackson ImmunoResearch), ﬂuorophore-
conjugated (IRDye 680 and IRDye 800CW; LI-COR Biosciences),
AlexaFluor488-conjugated anti-mouse and AlexaFluor568-con-
jugated anti-rabbit antibodies (Invitrogen).
2.4. Western blotting
HEK293T cells were lysed in RIPA buffer containing 1% Triton X-
100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris (pH 7.4),
150 mM NaCl, 0.5 mM EDTA, protease inhibitor cocktail (6 lg/ml
chymostatin, 0.5 lg/ml leupeptin, 10 lg/ml antipain, 2 lg/ml
aprotinin, 0.7 lg/ml pepstatin A and 10 lg/ml 4-amid-
inophenylmethanesulfonyl ﬂuoride hydrochloride; Sigma–Aldrich)
and phosphatase inhibitor cocktails (Sigma–Aldrich, cat# P0044,
P5726). Protein concentration was measured with BCA Protein
Assay Kit (Thermo Scientiﬁc). Samples of 10–50 lg total protein
were subjected to SDS–PAGE. Resolved proteins were transferred
to nitrocellulose membrane (Whatman), probed with speciﬁc anti-
bodies, and detected with enhanced chemiluminescence or Odys-
sey infrared imaging system (LI-COR Biosciences). Quantitative
analysis of bands detected on LI-COR Odyssey platform was per-
formed with Image Studio Software (LI-COR Biotechnology).
2.5. Immunoprecipitation and GST pull-down
Immunoprecipitation assay was performed as described previ-
ously [5].
GST, GST–APPL1-N (comprising 428 amino acids from the N-
terminus) and GST–APPL1-C (comprising amino acids 429–709),
GST–APPL2-N (comprising 377 amino acids from the N-terminus)
and GST–APPL2-C (comprising amino acids 378–664) fusion pro-
teins used in pull-down assays as baits were expressed and puri-
ﬁed according to the manufacturer’s instructions (GE Healthcare).
Isopropyl b-D-thiogalactoside (Sigma–Aldrich) at a concentration
of 0.5 mM was used to induce the expression. The lysates of Dvl2
overexpressing cells were incubated overnight at 4 C with con-
stant rotation with equal amounts of glutathione–Sepharose beads
(GE Healthcare) complexed with GST, GST–APPL1-N, GST–APPL1-C,
GST–APPL2-N or GST–APPL2-C fusion proteins. Beads were washed
5 times with the wash buffer used for immunoprecipitation. GST-
fusion proteins together with bound proteins were eluted with
10 mM glutathione in 50 mM Tris/HCl, pH 8.0, for 15 min at room
temperature with shaking. Eluates were resuspended in Laemmli
buffer, subjected to 10% SDS–PAGE and immunoblotted for the
proteins of interest.
2.6. Luciferase assays
HEK293T cells at 50–60% conﬂuence were transiently transfec-
ted with the appropriate plasmids and/or siRNA, and lysed with
passive lysis buffer (Promega). The following amounts of transfec-
ted plasmids were used in Fig. 2A and B: Dvl2 – 12.5 ng/well,
APPL1 – 12.5 ng/well, A-Fos – 25 ng/well; in Fig. 2C: Dvl2 – 6 ng/
well, APPL1 – 10 ng/well, APPL1mut1 – 37.5 ng/well, APPL1mut2
– 37.5 ng/well, APPL1mut3 – 75 ng/well (to obtain comparable
Table 1
List of primers used for RT-PCR.
Gene Forward primer Reverse primer
ACTB CAGGTCATCACCATTGGCAAT TCTTTGCGGATGTCCACGT
APPL1 GAGGACAGCCCGCAGACA TCCGATGCATAGCTTGATACAACT
B2M GGAGGCTATCCAGCGTACTC GAAACCCAGACACATAGCAATTC
DVL2 GCGCATCACCCTCGGCGATT ACACCAGCCAGGATACCACCCT
FOS CCTCGCCCGGCTTTGCCTAA AGAAGTCCTGCGCGTTGACAGG
JUN GCCAGGTCGGCAGTATAGTC TCTGGACACTCCCGAAACAC
JUNB GCACTAAAATGGAACAGCCCTT GGCTCGGTTTCAGGAGTTTG
JUND CCCCTTTCCTCGATCTCGC GAAAACAGAAAACCGGGCGAA
MMP1 CCCTCGCTGGGAGCAAACACA TTGTCCCGATGATCTCCCCTGAC
MMP2 CACCCATTTACACCTACACCAAGAAC TGCCAAGGTCAATGTCAGGAGAG
MMP13 GACTTCACGATGGCATTGCT GAAGTCGCCATGCTCCTTAATT
TEK CCAGGCTGATAGTCCGGAGAT AGCAGTACAGAGATGGTTGCATTC
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amount of DNA transfected was kept constant by co-transfection
with empty pcDNA3 vector. The obtained cell lysates were assayed
using the Fireﬂy Buffer [50 mM Tris pH 7.8, 12 mM MgCl2, 10 mM
DTT, 0.2 mM ATP (Sigma–Aldrich), 0.5 mM D-luciferin (Lux Bio-
technology #20052), 0.25 mM coenzyme A (Sigma–Aldrich)] or
Renilla Buffer [50 mM Tris pH 7.8, 100 mM NaCl, 2.5 nM coelenter-
azine (Lux Biotechnology #20001)]. Signals were measured in a
microplate luminometer (BMG Lumistar Galaxy or Berthold Tech-
nologies Centro XS3 LB 960). The ﬁreﬂy luciferase activity derived
from the AP-1-responsive reporter (pAP-1-luc; 50 ng/well) was
normalized to its respective Renilla luciferase activity driven by
TK promoter (pRL-TK; 10 ng/well). For experiments with JNK1/2
inhibitor (SP600125, Calbiochem), 5 h post-transfection cells wereFig. 1. APPL1 interacts with Dvl2. (A) and (B) Extracts of HEK293T cells transfected
immunoprecipitation (IP) using anti-Dvl2 or anti-Myc antibody; non-speciﬁc antibodi
immunoprecipitation. Transfection with the Myc-APPL2 construct leads to overproduc
untagged; see also Supplementary Fig. 1). Band indicated with ** represents unspeciﬁc b
HEK293T cells transfected for 24 h with Dvl2 was subjected to GST pull-down assay using
or APPL1-C, APPL2-N or APPL2-C, respectively). As a control, lysis buffer was used inste
lysate. M – molecular weight marker. The amounts of GST and GST-APPL1/2 fragment
extracts were analyzed by Western blotting using the indicated antibodies.treated with medium containing 40 lM SP600125 or control
(DMSO) and cultured for further 19 h. Reporter gene activity was
measured 24 h after transfection.
2.7. Cell fractionation and DNA-binding ELISA assay
HEK293T cells were transfected in 10 cm dishes with appropri-
ate plasmids for 24 h or with siRNA for 48 h and then with plasmid
DNA for the next 24 h, harvested and fractionated as described pre-
viously [5]. 10–20 lg of the obtained nuclear fractions were
assayed using the TransAM AP-1 Family kit according to the man-
ufacturer’s instructions (Active Motif, Inc.).
2.8. Quantitative RT-PCR
The total RNA was isolated with High Pure Isolation Kit (Roche).
For cDNA synthesis random nonamers, oligo(dT)23 and M-MLV
reverse transcriptase (Sigma–Aldrich) were used according to
manufacturer’s instructions.
The PCR reaction was performed with the Kapa Sybr Fast ABI
Prism qPCR Kit (KapaBiosystems) using a 7900HT Fast Real-Time
PCR thermocycler (Applied Biosystems). The DataAssist™Software
v3.0 was used to estimate fold change of gene expression versus
controls, employing housekeeping genes ACTB and B2M (encoding
actin B and beta-2-microglobulin, respectively) for normalization.
The expression values were obtained at least in duplicate. Oligonu-
cleotides for PCR reaction listed in Table 1 were custom-synthe-
sized by the Institute of Biochemistry and Biophysics (Warsaw,
Poland).for 24 h with Dvl2 and different APPL1 or APPL2 constructs were subjected to
es (IgG) were used as controls. Input indicates 10% of total cell extracts used for
tion of two forms of APPL2 protein (Myc-tagged indicated with an asterisk and
inding of highly overexpressed Myc-APPL2 to control antibodies (IgG). (C) Extract of
GST alone or GST fused to the N- or C-terminal parts of APPL1 and APPL2 (APPL1-N
ad of cell lysate (cell lysate, +cell lysate, respectively). Input indicates 20% of cell
s are shown by Ponceau staining (lower panel). (A)–(C) Bound proteins and input
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The data presented in Fig. 2A of six independent experiments
were subjected to the two tailed t-test, Dvl2 + APPL1 versus Dvl2,
⁄⁄P-value <0.01.
2.10. Immunoﬂuorescence
Cells grown on coverslips were ﬁxed with 3% paraformaldehyde
(15 min). Staining was performed as described previously [10].
Images were acquired on a laser-scanning confocal microscope
Leica TCS SP2 AOBS using a 63/1.4 numerical aperture oil immer-
sion objective. The presented images were arranged in Adobe
Photoshop CS 5.1 with linear adjustment.Fig. 2. APPL1 enhances the activation of the non-canonical Wnt pathway induced by Dv
transfected with the different combinations of plasmids, as indicated. Values are me
representative of at least three experiments. Data are normalized to the luciferase activit
APPL1 and Dvl2 overexpression were tested by Western blotting with GAPDH as a loa
activity. Statistical signiﬁcance is marked according to the two tailed t-test, ⁄⁄P < 0.01. (B
Mutants of APPL1 [APPL1mut1 (320A); APPL1mut2 (A318D) and APPL1mut3 (K280E/Y28
activity. (D) Dvl2 partially co-localizes with APPL1 in Hela cells. Arrows in magniﬁed in
APPL1 (red channel). Scale bar, 20 lm.3. Results and discussion
3.1. APPL1 interacts with Dvl2
Mass spectrometry analysis of protein complexes formed by
APPL1 and APPL2 revealed the presence of Dvl2, among many oth-
ers constituents [32]. To conﬁrm binding between Dvl2 and APPL
proteins, we performed reciprocal co-immunoprecipitations from
lysates of HEK293T cells co-transfected with APPL1 or APPL2 and
Dvl2, as no endogenous Dvl2 was detected in HEK293T cells. We
found APPL1 and APPL2 in immunoprecipitates of Dvl2 (Fig. 1A;
Supplementary Figs. 1 and 2), and vice versa (Fig. 1B) demonstrat-
ing an association between these proteins.l2. (A)–(C) Luciferase reporter assays were performed in HEK293T cells transiently
an ± S.E.M. from three independent transfections performed in parallel and are
y in pcDNA3-transfected cells, which was arbitrarily set to 1 unit of relative activity.
ding control (lower panels). (A) APPL1 potentiates Dvl2-dependent AP-1 reporter
) A-Fos expression abolishes effects of Dvl2 and APPL1 on the reporter activity. (C)
3C/G319R)] unable to localize to endosomes cannot potentiate Dvl2-driven reporter
set indicate co-localization of overexpressed Dvl2 (green channel) and endogenous
Fig. 3. APPL1 does not affect activity of AP-1 transcription factors. (A) Expression of AP-1 transcription factors in HEK293T cells upon Dvl2 overproduction measured by RT-
PCR in the absence or presence of JNK inhibitor SP600125. (B) Dvl2 increases c-Jun activation. Nuclear extracts of HEK293T cells (10 lg total protein) transfected as indicated
were assayed using the TransAM AP-1 Family kit for the activity of c-Jun. Nuclear extract of K-562 cells stimulated with TPA (5 lg) served as positive control (PC). To control
for speciﬁcity of the observed effects the nuclear extracts of Dvl2-transfected cells were incubated with the competing wild type (wt) and mutated (mut) oligonucleotides.
Values are mean ± S.E.M. from two experiments. (C) and (D) APPL1 does not affect Dvl2-dependent phosphorylation of c-Jun. The levels of total and active (phosphorylated at
Ser63, Ser73; P-cJun) c-Jun were analyzed by Western blotting in nuclear (NUC) fractions of HEK293T cells transfected with the indicated plasmids (C) and/ or siRNA (D; non-
targeting siRNA marked as CON). Lamin A/C was used as a loading control for nuclear fractions. The efﬁciency of APPL1 and Dvl2 overexpression and of APPL1 knockdown was
tested in total cell lysates (TCL) by Western blotting (with Ponceau staining in C or GAPDH immunoblot in D as loading controls).
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APPL proteins containing the PH and PTB domains, as the bacteri-
ally expressed fragments comprising amino acids 429–709 of
APPL1 and 378–664 of APPL2 fused to GST were able to pull down
Dvl2 from HEK293T cell lysate, whereas the N-terminal parts of
APPL were not (Fig. 1C). Since the efﬁciency of GST pull-down
was low, one cannot exclude that also other parts of APPL proteins
might be important for interaction with Dvl2 and/or proper folding
of APPL1/2. The differences in Dvl2 binding between the C-termi-
nal parts of APPL1 and APPL2 most probably reﬂect their different
stability (GST-APPL1-C is more prone to degradation, as shown by
Ponceau staining in Fig. 1C). In further studies we focused on
APPL1 for several reasons: (i) APPL1 is more abundant in HEK293T
cells than APPL2; (ii) the silencing efﬁciency of APPL1 is better than
for APPL2; (iii) there are biochemically well characterized mutants
of APPL1 useful for functional assays.
PDZ domains, such as the one present in Dvl2, preferentially
bind C-terminal peptides of interacting partners [33]. Therefore,
we tested binding between Dvl2 and APPL1 truncated at the
C-terminus by four amino acids (APPL1DC4), verifying that both
proteins still interacted (Fig. 1A). These data indicate that regions
other than the last four residues within the C-terminal part of
APPL1 enable association with Dvl2.3.2. APPL1 enhances the activation of non-canonical Wnt signaling
induced by Dvl2
Since we did not detect any clear impact of APPL1-Dvl2 interac-
tions on canonical Wnt signaling (Supplementary Fig. 2A and B),
we veriﬁed whether APPL1 may regulate the Dvl2 function in the
b-catenin-independent PCP pathway. To measure the activity of
non-canonical Wnt signaling in HEK293T cells we employed an
AP-1-driven luciferase reporter assay, a sensitive and reliable tool
to monitor activation of the JNK pathway [34–36]. In agreement
with previous reports, Dvl2 strongly (>10-fold) stimulated reporter
activity (Fig. 2A). APPL1 had no effect when overexpressed alone,
but in the presence of exogenously expressed Dvl2 it increased
the reporter activity. These results suggest that APPL1 can potenti-
ate the action of Dvl2 on AP-1 transcription in non-canonical Wnt
signaling.
To verify the assay speciﬁcity, we employed the DNA-binding
mutant of Fos transcription factor (A-Fos) which heterodimerizes
with c-Jun sequestering it and compromising AP-1-driven tran-
scription [31]. The data presented in Fig. 2B shows that A-Fos
expression: (i) reduced basal AP-1 reporter activity, (ii) abolished
Dvl2-dependent stimulation of luciferase activity, (iii) eliminated
the stimulatory effect of APPL1 onDvl2-dependent reporter activity.
Fig. 4. APPL1 affects expression of the MMP1 target gene in Dvl2-dependent
manner. RT-PCR was performed to measure transcription of the indicated non-
canonical Wnt target genes in HEK293T cells transiently transfected with Dvl2 and
APPL1. Data represent mRNA levels as fold change versus control (pcDNA3-
transfected cells). ACTB and B2M were used as reference genes. (A) Dvl2 overex-
pression stimulates MMP1 transcription. (B) Dvl2- and APPL1-regulated transcrip-
tion of MMP1 depends on the JNK activity. Before lysis, cells were treated with
DMSO or the JNK inhibitor SP600125. The effects of Dvl2 onMMP1 transcription are
represented as fold change versus pcDNA3-transfected, DMSO-treated control cells
or versus pcDNA3-transfected, SP600125-treated cells. Values are mean ± S.E.M.
from three experiments. The efﬁciency of APPL1 and Dvl2 overexpression was
tested by Western blotting with GAPDH as a loading control.
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affect AP-1 driven transcription operating in non-canonical Wnt
signaling.
3.3. Endosomal recruitment of APPL1 is necessary for its function in the
non-canonical Wnt pathway
Since APPL1 localizes mainly to endosomes, we examined the
relationship between its role in non-canonical Wnt signaling and
its cellular localization. We tested three previously described
mutants of APPL1 which cannot associate with Rab5 (APPL1-
K280E/Y283C/G319R and APPL1-A318D) or Rab21 (APPL1-
G320A) [3,4] and are therefore deﬁcient in binding to endosomal
membranes. When tested in the reporter assay, none of the
mutants was able to potentiate Dvl2-mediated AP-1 activity, in
contrast to the wild-type protein (Fig. 2C). While it cannot be
excluded that APPL1 mutants fail to affect the AP-1 pathway
because of reduced interactions with Dvl2, we consider it unlikely,
since the N-terminal part of APPL1 (where the mutations are
located) seems to be dispensable for Dvl2 binding. These results
may therefore suggest that endosomal fraction of APPL1 is respon-
sible for its function in Dvl2-dependent non-canonical Wnt signal-
ing. Since, by microscopy, we could observe residual co-
localization of APPL1 and Dvl2 on endosomes (Fig. 2D) recruitment
of Dvl2 to these organelles may be transient. APPL1 endosomal
localization was shown to be crucial for activation of the NF-jB
pathway [10], possibly due to its posttranslational modiﬁcations
or the presence of interacting proteins on endosomes. One might
speculate that endosomal APPL1 could be a part of a bigger plat-
form for dynamic assembly/disassembly of complexes involved
in non-canonical Wnt signaling. There are known examples of
interactions between endocytic proteins and Dvl which regulate
the non-canonical Wnt pathway. Binding of Dvl2 by AP-2, a clath-
rin adaptor complex, was shown to be crucial for Frizzled/PCP sig-
naling [37]. In Xenopus development, PCP signaling depends on the
interaction between Dvl homolog (Dsh) and an endocytic protein
b-arrestin 1 [38]. APPL1 may thus represent another link between
endocytosis and the non-canonical Wnt pathway.
3.4. Dvl2-dependent activation of c-Jun is not affected by APPL1
To understand the mechanism of Dvl2-APPL1 cooperation in
AP-1-dependent gene regulation, we started with proﬁling the
members of AP-1 family in HEK293T cells. First, we measured
the mRNA level of: c-Jun, JunB, JunD and cFos in HEK293T cells
overexpressing Dvl2. As shown in Fig. 3A, c-Jun, JunB and cFos,
but not JunD, were upregulated upon Dvl2 overexpression. In the
presence of JNK inhibitor SP600125 the effects of Dvl2 were elim-
inated which conﬁrmed the involvement of JNK in this process.
Next, we estimated activity of individual AP-1 transcription fac-
tors in nuclear extracts of HEK293T cells transfected with Dvl2 by
DNA-binding ELISA assay. We found that among six analyzed tran-
scription factors ﬁve of them: JunB, JunD, cFos, FosB, and Fra-1
were not activated by Dvl2 (data not shown), indicating that the
observed increase in transcript levels of cFos and JunB did not cor-
relate with activities of these proteins. Consistently with transcrip-
tional analysis, overexpression of Dvl2 led to about 2-fold
activation of c-Jun (measured as binding of Ser73-phosphorylated
c-Jun to oligonucleotides representing AP-1 binding sites)
(Fig. 3B). This effect was speciﬁc since addition of competing wild
type oligonucleotides abolished Dvl2-driven activation, while
addition of mutated oligonucleotides did not affect it. These
observations show that in HEK293T cells Dvl2 acts via the c-Jun
transcription factor. Consistently, immunoblotting of nuclear
extracts for c-Jun phosphorylated at Ser63 and Ser73 conﬁrmed
its increased levels in cells overexpressing Dvl2 (Fig. 3C and D).However, the abundance of this active c-Jun form remained
unchanged upon additional overexpression (Fig. 3C) or silencing
(Fig. 3D) of APPL1, excluding any direct impact of APPL1 on c-Jun
activation. Nevertheless, it should be noted that other active forms
of c-Jun exist [39] which were not assayed in our study and could
be potentially affected by APPL1. Moreover, c-Jun is one of numer-
ous substrates of the JNK kinase [40] and it remains possible that
APPL1 could, via Dvl2, act on transcription factors others than
the examined AP-1 members.
3.5. APPL1 modulates expression of the MMP1 gene
Since APPL1 was able to increase Dvl2-dependent AP-1 reporter
activity, we tested whether APPL1 could modulate expression of
non-canonical Wnt target genes. First, we employed HEK293T cells
overproducing APPL1 or Dvl2 proteins and measured expression
levels of four AP-1 target genes (MMP1, MMP2, MMP13 encoding
metalloproteinases and TEK encoding angiotensin receptor Tie2),
known to be upregulated by non-canonical Wnt5a ligand [41,42]
538 M. Banach-Orlowska et al. / FEBS Letters 589 (2015) 532–539or by Dvl2 overexpression in distinct cell lines [43]. As depicted in
Fig. 4A, Dvl2 overexpression induced transcription only of the
MMP1 gene, whereas APPL1 overexpression alone had no effect.
However, in cells transfected with Dvl2, APPL1 overproduction fur-
ther increased the level of MMP1 transcript (Fig. 4B), in full agree-
ment with the reporter data (Fig. 2A).
To examine if the observed effects were dependent on the JNK
pathway, as reported for the role of Dvl2 in non-canonical Wnt sig-
naling [21,22], we employed JNK inhibitor SP600125 in HEK293T
cells overexpressing Dvl2 alone or with APPL1. Data presented in
Fig. 4B shows that JNK inhibition severely reduced the stimulatory
effect of Dvl2 on MMP1 transcription. The remaining stimulatory
effect of Dvl2 can be explained by incomplete inhibition of JNK
or by an additional JNK-independent pathway involving Dvl2 in
the regulation of MMP1 expression. In the presence of SP600125,
APPL1 was no more able to increase transcription of MMP1
(Fig. 4B). These results indicate that in HEK293T cells APPL1 mod-
ulates Dvl2-driven expression of MMP1 via a mechanism involving
the JNK kinase.
The exact mechanism of APPL1 action in Dvl2-mediated gene
expression will require further investigation. Since APPL1 mutants
deﬁcient in endosome localization failed to potentiate Dvl2 func-
tion in regulation of AP-1 dependent transcription, one may spec-
ulate that APPL1 residing on endosomes provides a proper context
for Dvl2 activity. Taking into account the role of APPL1 in canonical
Wnt signaling, it is plausible that APPL1 can act as a switch
between canonical and non-canonical Wnt signaling. APPL1 seems
to affect these two branches of Wnt signaling at different stages:
the non-canonical pathway at an early stage involving Dvl2 and
the canonical one at a late stage by attenuating reptin-dependent
transcriptional repression in the nucleus [11]. Being an adaptor
protein capable of multiple interactions in various cellular loca-
tions, APPL1 can function in many signaling pathways and is a
good candidate for a ﬁne tuner of cellular signaling. We postulate
that APPL1 may act as such modulator also in Dvl-induced non-
canonical Wnt signaling network.
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